Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8251-8300 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05540392
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Sep 9, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor8 locations
NCT05434858
Imagery as Biomarker of Gout
NAActive, not recruiting
21 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2029
1 condition2 sponsors1 location
NCT05437406
Family, Responsibility, Education, Support, and Health for Latino Caregivers (FRESH-LC)
NAActive, not recruiting
167 participants
Started: Sep 8, 2022 · Completed: Oct 31, 2026
2 conditions5 sponsors1 location
NCT05276973
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
PHASE1Active, not recruiting
25 participants
Started: Sep 8, 2022 · Completed: Feb 26, 2026
18 conditions2 sponsors8 locations
NCT05272423
Studying Pathways of Resistance in KRAS-driven Cancers
N/AActive, not recruiting
500 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT04788004
Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
N/AActive, not recruiting
733 participants
Started: Sep 8, 2022 · Completed: Jul 20, 2026
1 condition1 sponsor1 location
NCT05454839
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
N/AActive, not recruiting
1,098 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors2 locations
NCT05625737
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
PHASE2Active, not recruiting
29 participants
Started: Sep 8, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05528263
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
NAActive, not recruiting
89 participants
Started: Sep 8, 2022 · Completed: Feb 28, 2026
6 conditions2 sponsors1 location
NCT05209074
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
PHASE1Active, not recruiting
16 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05551052
CRC Detection Reliable Assessment With Blood
N/AActive, not recruiting
196 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2027
16 conditions1 sponsor3 locations
NCT05570058
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
PHASE2Active, not recruiting
48 participants
Started: Sep 8, 2022 · Completed: Jan 9, 2025
2 conditions2 sponsors31 locations
NCT05540782
A Study of Cognitive Health in Survivors of Prostate Cancer
N/AActive, not recruiting
200 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2026
2 conditions1 sponsor7 locations
NCT05561829
Determination of Optimal Sleep Treatment Elements - MOST
NAActive, not recruiting
489 participants
Started: Sep 8, 2022 · Completed: May 31, 2024
1 condition3 sponsors1 location
NCT05442203
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
NAActive, not recruiting
1,000 participants
Started: Sep 7, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor3 locations
NCT05621759
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
PHASE2Active, not recruiting
27 participants
Started: Sep 7, 2022 · Completed: Aug 23, 2026
1 condition1 sponsor1 location
NCT05264714
Cluster Headache Treatment With Rimegepant
PHASE2Active, not recruiting
10 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05388760
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
PHASE2Active, not recruiting
24 participants
Started: Sep 7, 2022 · Completed: Apr 23, 2026
1 condition1 sponsor11 locations
NCT05425940
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
PHASE3Active, not recruiting
901 participants
Started: Sep 7, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor133 locations
NCT05470283
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
PHASE1Active, not recruiting
21 participants
Started: Sep 7, 2022 · Completed: Apr 1, 2027
3 conditions1 sponsor1 location
NCT05621798
Quantifying the Benefits and Cost-effectiveness of Real-Ear Measurements (REM) for Hearing Aid Fitting
NAActive, not recruiting
101 participants
Started: Sep 7, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT06303791
Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders
NAActive, not recruiting
90 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05566847
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
NAActive, not recruiting
817 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT05434481
MITAORTA - Role of Mitochondrial Dynamic in Aneurysm and Dissection of Ascending Thoracic Aorta
NAActive, not recruiting
60 participants
Started: Sep 7, 2022 · Completed: Oct 23, 2024
1 condition2 sponsors1 location
NCT05440643
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
PHASE1/PHASE2Active, not recruiting
192 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors40 locations
NCT04522739
Spironolactone Safety in African Americans with Mild Cognitive Impairment and Early Dementia
PHASE4Active, not recruiting
30 participants
Started: Sep 6, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT05503082
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
PHASE4Active, not recruiting
164 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2024
1 condition2 sponsors2 locations
NCT04927364
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
NAActive, not recruiting
8 participants
Started: Sep 6, 2022 · Completed: Jul 1, 2025
2 conditions2 sponsors1 location
NCT05459298
ViDES Trial (Vitamin D Extra Supplementation)
NAActive, not recruiting
180 participants
Started: Sep 6, 2022 · Completed: Dec 1, 2027
1 condition3 sponsors1 location
NCT05520528
Impact of Group Participation on Adults With Aphasia
NAActive, not recruiting
40 participants
Started: Sep 6, 2022 · Completed: Dec 15, 2026
4 conditions1 sponsor1 location
NCT05316584
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
NAActive, not recruiting
123 participants
Started: Sep 6, 2022 · Completed: Jul 1, 2025
3 conditions6 sponsors5 locations
NCT05627128
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
NAActive, not recruiting
150 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2025
1 condition3 sponsors2 locations
NCT05471843
Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
PHASE1/PHASE2Active, not recruiting
125 participants
Started: Sep 5, 2022 · Completed: Jan 31, 2027
3 conditions1 sponsor104 locations
NCT05516264
Behavioural and Physiological Responses to Dog Visits in Nursing Homes
NAActive, not recruiting
50 participants
Started: Sep 5, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05399381
Traveling-wave Transcranial Electric Stimulation
NAActive, not recruiting
30 participants
Started: Sep 5, 2022 · Completed: Feb 1, 2026
1 condition2 sponsors1 location
NCT04074096
Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis
PHASE2Active, not recruiting
10 participants
Started: Sep 5, 2022 · Completed: Apr 15, 2029
3 conditions4 sponsors21 locations
NCT05890274
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
NAActive, not recruiting
120 participants
Started: Sep 4, 2022 · Completed: Feb 28, 2026
1 condition4 sponsors3 locations
NCT05156892
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer
PHASE1Active, not recruiting
44 participants
Started: Sep 4, 2022 · Completed: Jan 1, 2027
1 condition5 sponsors1 location
NCT05344183
Immediate and Short-term Effects of Low-level Laser
NAActive, not recruiting
24 participants
Started: Sep 3, 2022 · Completed: Dec 12, 2024
2 conditions1 sponsor1 location
NCT05496959
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
PHASE2Active, not recruiting
93 participants
Started: Sep 2, 2022 · Completed: Sep 1, 2033
4 conditions2 sponsors1 location
NCT06027567
The Effect of an Anti-obesity Drug, Semaglutide, As Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (dietician) with Regards to Change in Weight and Intracranial Pressure
PHASE4Active, not recruiting
50 participants
Started: Sep 2, 2022 · Completed: Oct 30, 2025
6 conditions4 sponsors2 locations
NCT05398627
Neurofeedback for Borderline Personality Disorder
NAActive, not recruiting
100 participants
Started: Sep 2, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06116240
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
135 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor12 locations
NCT05530551
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
NAActive, not recruiting
20,000 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
3 conditions7 sponsors36 locations
NCT05499949
The Franciscus Obesity NASH Study
N/AActive, not recruiting
300 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2029
3 conditions4 sponsors1 location
NCT05522426
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting
NAActive, not recruiting
50 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT04271332
Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion
PHASE2Active, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Mar 23, 2025
1 condition1 sponsor4 locations
NCT05673941
"InMotion - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia"
NAActive, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05545228
The Mouth Matters in Mental Health Study
NAActive, not recruiting
79 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2024
1 condition1 sponsor5 locations
NCT05445349
Breathing Parameter Measurements for Lung Deposition Simulation
N/AActive, not recruiting
163 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
2 conditions7 sponsors3 locations